Kyoung-Sik Moon
Overview
Explore the profile of Kyoung-Sik Moon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
355
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jeong S, Park D, Park T, Han J, Lee J, Choi C, et al.
Heliyon
. 2024 Dec;
10(23):e40559.
PMID: 39687194
Background: Xenogeneic transplantation induces acute graft-versus-host disease (aGvHD) and subsequent vital organ damage. Herein, we aimed to examine hepatic damage associated with aGvHD using histopathology and gene expression profiles. Methods:...
2.
Jung H, Kyun M, Kwon J, Kim J, Kim J, Park D, et al.
Biomater Sci
. 2024 Nov;
12(24):6351-6367.
PMID: 39483068
Liver fibrosis, a critical consequence of chronic liver diseases, is characterized by excessive extracellular matrix (ECM) deposition driven by inflammation. This process involves complex interactions among hepatocytes, hepatic stellate cells...
3.
Kim I, Kyun M, Jung H, Kwon J, Kim J, Kim J, et al.
ACS Omega
. 2024 Jun;
9(23):25094-25105.
PMID: 38882105
Nonalcoholic fatty liver disease (NAFLD), which is a major cause of chronic liver disease, is characterized by fat accumulation in the liver. Existing models struggle to assess medication effects on...
4.
Cyclosporine A-induced systemic metabolic perturbations in rats: A comprehensive metabolome analysis
Yen N, Tien N, Anh N, Le Q, Eunsu C, Kim H, et al.
Toxicol Lett
. 2024 Mar;
395:50-59.
PMID: 38552811
A better understanding of cyclosporine A (CsA)-induced nephro- and hepatotoxicity at the molecular level is necessary for safe and effective use. Utilizing a sophisticated study design, this study explored metabolic...
5.
Bak I, Choi M, Yu E, Yoo K, Jeong S, Lee J, et al.
Transplant Proc
. 2024 Feb;
56(2):440-447.
PMID: 38368129
Background: Humanized mouse models with engraftment of human peripheral blood mononuclear cells (PBMCs) or hematopoietic stem cells (HSCs) are effective tools for the study of human immunity. Busulfan has been...
6.
Cho H, Min J, Choi M, Jeong S, Moon K, Lee J, et al.
ACS Omega
. 2023 Nov;
8(44):41728-41736.
PMID: 37970034
MicroRNA (miRNA) has recently garnered significant research attention, owing to its potential as a diagnostic biomarker and therapeutic target. Liquid chromatography-mass spectrometry (LC-MS) offers accurate quantification, multiplexing capacity, and high...
7.
Han J, Lee Y, Lee J, Chung H, Lee G, Nam Y, et al.
Mol Ther Nucleic Acids
. 2023 Nov;
34:102050.
PMID: 37916225
Gene therapy and rebalancing therapy have emerged as promising approaches for treating hemophilia A, but there are limitations, such as temporary efficacy due to individual differences. Genome editing for hemophilia...
8.
Kyun M, Park T, Jung H, Kim I, Kwon J, Jeong S, et al.
Tissue Eng Regen Med
. 2023 Oct;
20(7):1173-1190.
PMID: 37843784
Background: The emergence of various infectious diseases and the toxic effects of hyperinflammation by biotherapeutics have highlighted the need for in vitro preclinical models mimicking the human immune system. In...
9.
Yen N, Phat N, Oh J, Park S, Moon K, Thu V, et al.
Toxicol Appl Pharmacol
. 2023 Jun;
473:116597.
PMID: 37321324
Tacrolimus (TAC)-based treatment is associated with nephrotoxicity and hepatotoxicity; however, the underlying molecular mechanisms responsible for this toxicity have not been fully explored. This study elucidated the molecular processes underlying...
10.
Park S, Kim D, Choi M, Han K, Han J, Yoo K, et al.
Hum Exp Toxicol
. 2023 Apr;
42:9603271231171650.
PMID: 37092667
The potential of human mesenchymal stem cells (MSCs) for cell therapy has been investigated in numerous immune-mediated conditions; MSCs are considered one of the most promising cellular therapeutics to treat...